EMA: Routine Inspections to Focus On Pharmacovigilance Compliance

The EU’s drugs authority is advising manufacturers that routine inspections will now include a focus on compliance with pharmacovigilance reporting requirements. Serious violators will face the Pharmacovigilance Risk Assessment Committee.
International Pharmaceutical Regulatory Monitor